88 related articles for article (PubMed ID: 76351)
1. Antigens and receptors involved in bone marrow transplantation.
Klein J
Transplant Proc; 1978 Mar; 10(1):5-9. PubMed ID: 76351
[No Abstract] [Full Text] [Related]
2. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
[TBL] [Abstract][Full Text] [Related]
3. Adaptive phenomena in bone marrow transplantation.
Goujet-Zalc C; Ilbery PL
Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
[No Abstract] [Full Text] [Related]
4. A class II antigen-specific T cell clone can suppress graft-versus-host reactivity in murine allogeneic bone marrow chimeras.
Shih CC; Truitt RL
Transplant Proc; 1987 Feb; 19(1 Pt 3):2664-7. PubMed ID: 2950639
[No Abstract] [Full Text] [Related]
5. H-2 restriction of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers in mice.
Korngold R; Sprent J
Transplant Proc; 1981 Mar; 13(1 Pt 2):1217-9. PubMed ID: 7022928
[No Abstract] [Full Text] [Related]
6. Lethal graft-versus-host reaction to minor histocompatibility antigens is decreased by donor immunization against H-2 and varies as a function of the H-2 haplotype.
Halle-Pannenko O; Pritchard LL; Motta R; Mathe G
Transplant Proc; 1979 Mar; 11(1):652-6. PubMed ID: 36701
[No Abstract] [Full Text] [Related]
7. [Dominant role of the genes of the K region in the mouse H-2 system in macrophage induction of T effectors of the graft vs host reaction].
Anfalova TV; Galaktionov VG; Lutsan NI; Golenishchev VG; Kapinus LN
Dokl Akad Nauk SSSR; 1984; 279(4):1016-20. PubMed ID: 6151888
[No Abstract] [Full Text] [Related]
8. Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host.
Hummel S; Wilms D; Vitacolonna M; Zöller M
J Leukoc Biol; 2002 Nov; 72(5):898-912. PubMed ID: 12429711
[TBL] [Abstract][Full Text] [Related]
9. Minor histocompatibility genes important in lethal graft-versus-host reaction (GVHR): chromosomal assignment of five genes using ten chromosomal markers.
Motta R; Moutier R; Halle-Pannenko O
Transplant Proc; 1981 Mar; 13(1 Pt 2):1207-14. PubMed ID: 7022927
[No Abstract] [Full Text] [Related]
10. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency.
Hakim FT; Shearer GM
J Immunol; 1986 Nov; 137(10):3109-16. PubMed ID: 3095424
[TBL] [Abstract][Full Text] [Related]
12. Antilymphocytic antibodies and marrow transplantation. V. Suppression of secondary disease by host-versus-theta-graft reaction.
Thierfelder S; Rodt H
Transplantation; 1977 Jan; 23(1):87-92. PubMed ID: 319574
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of T lymphocytes and hematopoietic precursor cells to photochemotherapy with 8-methoxypsoralen and ultraviolet A light.
Mabed M; Coffe C; Racadot E; Angonin R; Pavey JJ; Tiberghien P; Herve P
Ann Hematol; 2006 Jan; 85(1):17-24. PubMed ID: 16208471
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation in inbred strains of mice. I. The failure of development of normal T cell function following allogeneic transplantation.
Trier L; Rubin B
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):724-32. PubMed ID: 4139875
[No Abstract] [Full Text] [Related]
15. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L
Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
[No Abstract] [Full Text] [Related]
16. Detection of non-HLA antibodies in bone marrow transplant recipients.
Opelz G; Walker J; Gale RP
Transplant Proc; 1978 Dec; 10(4):963-4. PubMed ID: 83728
[No Abstract] [Full Text] [Related]
17. [Increased efficacy of allogenic bone marrow transplantation].
Fedotenkov AG; Danilova LA; Ignasheva LP
Biull Eksp Biol Med; 1982 Aug; 94(8):104-8. PubMed ID: 6751429
[TBL] [Abstract][Full Text] [Related]
18. Detection of anti-non-MHC-directed T cell reactivity following in vivo priming after HLA-identical marrow transplantation and following in vitro priming in limiting dilution cultures.
Irlé C; Chapuis B; Jeannet M; Kaestli M; Montandon N; Speck B
Transplant Proc; 1987 Feb; 19(1 Pt 3):2674-7. PubMed ID: 3547946
[No Abstract] [Full Text] [Related]
19. Mutual recognition of parental and F lymphocytes. III. Parental determinants recognized by F host mice in resistance to graft-vs-host-associated immunosuppression map to H-2Db.
Shearer GM; Polisson RP
J Immunol; 1981 Feb; 126(2):545-7. PubMed ID: 6161180
[No Abstract] [Full Text] [Related]
20. Mismatching for minor histocompatibility antigens in bone marrow transplantation: consequences for the development and control of severe graft-versus-host disease.
Mathé G; Pritchard LL; Halle-Pannenko O
Transplant Proc; 1979 Mar; 11(1):235-9. PubMed ID: 377638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
